Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells

Redox Biol. 2017 Aug:12:403-409. doi: 10.1016/j.redox.2017.03.013. Epub 2017 Mar 10.

Abstract

Cancer cells have an altered redox status, with changes in intracellular signaling pathways. The knowledge of how such processes are regulated in 3D spheroids, being well-established tumor models, is limited. To approach this question we stably transfected HCT116 cells with a pTRAF reporter that enabled time- and cell-resolved activity monitoring of three redox-regulated transcription factors Nrf2, HIF and NF-κB in spheroids enriched for cancer stem cells. At the first day of spheroid formation, these transcription factors were activated and thereafter became repressed. After about a week, both HIF and Nrf2 were reactivated within the spheroid cores. Further amplifying HIF activation in spheroids by treatment with DMOG resulted in a dominant quiescent stem-cell-like phenotype, with high resistance to stress-inducing treatments. Auranofin, triggering oxidative stress and Nrf2 activation, had opposite effects with increased differentiation and proliferation. These novel high-resolution insights into spatiotemporal activation patterns demonstrate a striking coordination of redox regulated transcription factors within spheroids not occurring in conventional cell culture models.

Keywords: Cancer stem cells; HIF; NF-κB; Nrf2; Redox regulation; Spheroids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Dicarboxylic / pharmacology
  • Cell Culture Techniques
  • Gene Expression Regulation, Neoplastic / drug effects
  • HCT116 Cells
  • Humans
  • Hypoxia-Inducible Factor 1 / genetics*
  • Models, Biological
  • NF-E2-Related Factor 2 / genetics*
  • NF-kappa B / genetics*
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / metabolism*
  • Oxidation-Reduction
  • Spheroids, Cellular / drug effects
  • Spheroids, Cellular / metabolism*
  • Transcriptional Activation

Substances

  • Amino Acids, Dicarboxylic
  • Hypoxia-Inducible Factor 1
  • NF-E2-Related Factor 2
  • NF-kappa B
  • NFE2L2 protein, human
  • oxalylglycine